A Non-interventional Study Evaluating Clinical Utility and Implications on Improved Patient Management of Serum Neurofilament as a Prognostic Marker for Disease Activity in Patients With Relapsing Multiple Sclerosis
Clinical trial NCT06551519 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06551519
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-10-28
- Primary completion
- 2028-11-29
- Enrollment
- 489
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.